Insider Activity of LEWIS JOEL
According to the SEC Form 4 filings, LEWIS JOEL, being in a position of
- President and CEO at Galectin Therapeutics Inc.,оver the last 12 months, has bought 0 shares, and sold 130779 shares for $612,723,over all time since 2018-06-25, has bought 18516 shares for $79,465, and sold 202079 shares for $759,195.
Biography of LEWIS JOEL
No biography is available at this moment.